{"job":{"jobId":2374502,"fk_accountId":439,"fk_organizationId":3353,"fk_adminAccountId":null,"title":"서울아산병원 울산대학교 의과대학 박찬식교수님 연구실 박사후연구원 모집","description":"<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">본 연구실은 사람의 면역기전 및 항암면역학에 대하여 연구를 수행하고 있습니다</span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">. 환자샘플, 종양이식 및 생체유사환경 모델, CRISPR등을 이용하여 기초와 임상을 아우르는 중계연구를 진행하고 있습니다. 소규모 실험실이지만 연구경험이 많은 임상의와 실험 실무를 잘아는 연구교수가 열심히 연구하며, 자율적이며 활발한 토론이 자주 이루어지는 분위기이고, 비교적 풍부한 연구비가 확보되어 있습니다. 본 연구실에서 진취적이고 주도적으로 연구에 함께하실 박사후 연구원(postdoc)을 모집합니다! </span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\"> 육아등의 사유로 경력이 단절된 분이나, 경력이 좀더 있는 연구교수급(박사졸업 후 관련 경력 3년 이상, SCI 논문 2편 이상)도 지원 가능합니다. 이곳에서의 훈련을 통해 바이오회사에 취직하려는 분들도 환영합니다.</span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"> </p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">업무내용</span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">: </span></span></span></span></span></span></p>\n\n<ol>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">CRISPR library screening 관련 전반(cloning, NGS-fastq- 분석 등)</span></span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">사람 면역 세포 배양</span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">(organ culture model등) 및 동물실험</span></span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">연구논문</span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">, 연구비 계획서, 보고서 작성등</span></span></span></span></span></li>\n</ol>\n\n<p style=\"text-align:start\"> </p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">연구주제</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">:</span></span></span></span></span></p>\n\n<ol>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">CRISPR screening을 통한 immune checkpoint 기전 및 유전자 기능 탐색</span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">각종</span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\"> B 림프종의 신약 후보 및 바이오마커(biomarker)의 발현연구</span></span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">면역치료제</span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">(immune checkpoint inhibitor; anti-PD-1, VSIG4등) 작용기전 및 병용요법 연구</span></span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">사람 </span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">B 세포 기능연구 (상대적으로 연구가 미흡한 부분이나, COVID 및 각종 난치병에서 Rituxan 효과등으로 그 중요성이 새로 각광받고 있음.)</span></span></span></span></span></li>\n</ol>\n\n<p style=\"text-align:start\"> </p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">채용조건</span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">: 박사 졸업</span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">연봉</span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">: 40,000,000~52,000,000, 경력에 따른 차등 지급 (연구교수급은 경력에 따라 인상), 4대보험 적용, 주5일 근무</span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"> </p>\n\n<p style=\"text-align:start\"> </p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">지원사항</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">:</span></span></span></span></span></p>\n\n<ol>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">신축건물의 깔끔하고 쾌적한 연구환경</span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">공원</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">,원내 헬스장, 직원 라운지, 직원 수영장등 이용 가능</span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">출퇴근 버스 및 식비지원</span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">1년 이상 근무시 병원비 50%할인</span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">첨단 시설과</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">, 풍부한 실험장비, 코어랩 운영을 통한 대규모 고가 장비 이용 및 기술지원.</span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">대학원생 또는 연구원 한명</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">, 공동연구자로 지원 </span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">직원 주차장 이용 가능</span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">직원 릴렉스</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">(마사지) 서비스 제공</span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">콘도</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">(대명리조트, 한화리조트, 켄싱턴리조트, 웰리힐리파크, 대천 웨스토피아) 및 하계 휴양소(동.서해안) 이용 가능</span></span></span></span></li>\n</ol>\n\n<p style=\"text-align:start\"> </p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">본 연구실의 장점</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">:</span></span></span></span></span></p>\n\n<ol>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">풍부한 연구비 확보</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">.</span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">첨단 실험기법 구축</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">(CRISPR를 이용한 유전자 조작, 사람 B 세포 분화 시스템, 유전자도입이 극도로 어려운 세포의 고효율 유전자도입 기법, 한번에 10 가지 단백질을 염색할 수 있는 면역조직화학법 등).</span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">다양한 주제의 연구가 진행중에 있어 논문 작성의 기회가 많음</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">. 활발한 영어 논문 작성 디스커션을 통한 높은 완성도의 논문 게제</span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">미국등에서 오래 연구한 지도교수의 지도아래 </span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">영어논문 작성에 대하여 확실한 기초를 다질 수 있음</span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">환자 검체를 이용한 다양한 첨단 연구기법</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">(환자조직 다중염색, NGS 분석, deep-learning등)을 경험할 수 있음</span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">지도교수님과 토론식 교육을 통하여</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">, 논문 강독, 실험결과 해석 및 연구계획 수립 과정의 심도있는 수련(주1회 실험결과토론과 주1회 개별논문토론을 1:1로 진행)</span></span></span></span></li>\n\t<li style=\"text-align:justify\"><span style=\"font-size:10pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">연구 프로젝트에 따라 제약회사 및 바이오벤처 기업들과 협력연구 기회제공</span></span></span></span></li>\n</ol>\n\n<p style=\"text-align:start\"> </p>\n\n<p style=\"text-align:start\"> </p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">전형방법 </span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">면접 및 서류전형</span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"> Email : <span style=\"color:#0563c1\"><u><a href=\"mailto:csikpark@amc.seoul.kr\" style=\"color:#954f72; text-decoration:underline\">csikpark@amc.seoul.kr</a></u></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"> </p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">1. 이력서와 자기소개서(하나의 워드파일로 제출), </span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">이력서와</span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\"> 실험과 관한 자기소개서(가능한 실험 기법, 지도교수님 성함, 논문 출판등에 대한 간략한 기술)를 한개의 워드파일로 만들어 e-mail로 제출.</span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">2. </span></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">출간논문 </span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\">pdf</span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"> </span></span></span></p>\n\n<p style=\"text-align:start\"> </p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\"><최근 3년간 연구 실적></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">SCIENTIFIC REPORTS, <strong>20200630</strong>, Quantitative Analysis of Tumor-Specific BCL2 Expression in DLBCL: Refinement of Prognostic Relevance of BCL2, 2045-2322, 10, 1, 노진,조형우,윤덕현,홍정용,A Lee,HS Eom,H Lee,WS Park,JH Han,JS Park,H, Pak,Hyo-Kyung, 김소운, 김상엽, 서철원, 허주영, 박찬식, <strong>IF=4.011</strong></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">LEUKEMIA LYMPHOMA, <strong>20200501</strong>, Distinct clinical characteristics at diagnosis in patients with late relapses compared with early relapses of diffuse large B-cell lymphoma treated with R-CHOP, 1042-8194, 61, 강준호, 김신, 류진숙, 박정선, 박찬식, 서철원, 윤덕현, 이상욱, 채희정, 허주영, 홍정용, <strong>IF=3.093</strong></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">Frontiers in Oncology, <strong>20200301</strong>, Risk Stratification Using Multivariable Fractional Polynomials in Diffuse Large B-Cell Lymphoma, 2234-943X, 10, 32, 노진,정지원,이유림, 김소운, 박효경, 이아늠, 이준호, 조재형, 조형우, 윤덕현, 박래웅, 허주영, 오흥범, 박찬식, <strong>IF=4.848</strong></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">Annals of Laboratory Medicine, <strong>20200101</strong>, JL1 Antigen Expression on Bone Marrow Lymphoma Cells from Patients With Non-Hodgkin Lymphoma, 2234-3806, 40, 1, 김민선, 박찬식, 박찬정, 서을주, 서종진, 서철원, 윤덕현, 임호준, 장성수, 조영욱, 허주영, <strong>IF=2.803</strong></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">NATURE COMMUNICATIONS, <strong>20191004</strong>, Genetic modification of primary human B cells to model high-grade lymphoma, 2041-1723, 10, 4543, Rebecca Caeser, Miriam Di Re, Joanna A. Krupka, Jie Gao, Maribel Lara-Chica, João M. L. Dias, Susanna L. Cooke, Rachel Fenner, Zelvera Usheva, Hendrik F. P. Runge, Philip A. Beer, Hesham Eldaly, Hyo-Kyung Pak, Chan-Sik Park, George S. Vassiliou, Brian J. P. Huntly, Annalisa Mupo, Rachael J. M. Bashford-Rogers & Daniel J. Hodson, <strong>IF=11.88</strong></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">INTERNATIONAL JOURNAL OF HEMATOLOGY, <strong>20190701</strong>, Systemic HD-MTX for CNS prophylaxis in high-risk DLBCL patients: a prospectively collected, single-center cohort analysis, 0925-5710, 110, 1, 강은희, 김신, 박찬식, 서철원, 윤덕현, 이경민, 이상욱, 허주영, 홍정용, <strong>IF=1.942</strong></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">ANNALS OF HEMATOLOGY, <strong>20190701</strong>, Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma, 0939-5555, 98, 7, 김신, 김정훈, 류진숙, 박정선, 박찬식, 서철원, 윤덕현, 이상욱, 허주영, 형재원, 홍정용, <strong>IF=2.85</strong></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">ANNALS OF HEMATOLOGY , <strong>20181201</strong>, The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms, 0939-5555, 97, 12, 고영혜, 김석진, 김원석, 박찬식, 서철원, 윤덕현, 이윤세, 허주영, 홍정용, 황희상, <strong>IF=2.85</strong></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">JOURNAL OF CUTANEOUS PATHOLOGY, <strong>20181201</strong>, Expression of hormone receptors, adipophilin, and GCDFP-15 in mucinous carcinoma of the skin, 0303-6987, 45, 12, 노진,박찬식,성유나,이윤세,조경자,최승호,최종우, <strong>IF=1.373</strong></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">FRONTIERS IN IMMUNOLOGY, <strong>20180722</strong>, Human Plasmablast Migration Toward CXCL12 Requires Glucose Oxidation by Enhanced Pyruvate Dehydrogenase Activity via AKT, 1664-3224, 9, 1742, 박효경, 남보라, 이윤경, 김용우, 노진, 손재경, 정유삼, 최종선, 박찬식, <strong>IF=5.085</strong></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">BLOOD, <strong>20180426</strong>, Alterations in the Rho pathway contribute to Epstein-Barr virus-induced lymphomagenesis in immunosuppressed environments, 0006-4971, 131, 17, 강원영, 강진주, 고영혜, 공성호, 곽은영, 김우호, 김종일, 김주영, 김현수, 나득채, 노진, 민소연, 박상희, 박성열, 박찬식, 박한수, 박효경, 서윤석, 성창옥, 양한광, 이다근, 이아라, 이지은, 이혁준, 제임스 퀙, 조민선, 조성엽, 주영석, 체프 청, 최보람, 최지수, Charles Lee, Edison T. Liu, Jacques Banchereau, <strong>IF=16.601</strong></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">HEMATOLOGICAL ONCOLOGY, <strong>20180201</strong>, Complete metabolic response (CMR) in positron emission tomography-computed tomography (PET-CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL), 0278-0232, 36, 1, 김신, 류진숙, 박지현, 박찬식, 서철원, 이상욱, 허주영, <strong>IF=3.439</strong></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, <strong>20180101</strong>, Cereblon deficiency confers resistance against polymicrobial sepsis by the activation of AMP activated protein kinase and heme-oxygenase-1, 0006-291X, 495, 1, 길민찬, 김윤규, 김하영, 박찬식, 박효경, 이경진, IF<strong>=2.705</strong></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">ANNALS OF HEMATOLOGY , <strong>20170901</strong>, Interim 18F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine, 0939-5555, 96, 9, 강은희, 김신, 김종훈, 류진숙, 박정선, 박찬식, 서철원, 윤덕현, 이경민, 이상욱, 조재철, 허주영, <strong>IF=2.85</strong></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">APPLIED IMMUNOHISTOCHEMISTRY MOLECULAR MORPHOLOGY, <strong>20170901</strong>, Dermatofibrosarcoma Protuberans: An Immunomarker Study of 57 Cases That Included Putative Mesenchymal Stem Cell Markers, 1541-2016, 25, 8, 김은주, 박찬식, 송준선, 조경자, <strong>IF=1.863</strong></span></span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:medium\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Batang,serif\"><span style=\"color:black\">ONCOTARGET, <strong>20170722</strong>, The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma, 1949-2553, 8, 35, 김연미, 노진, 박찬식, 박찬정, 서철원, 성창옥, 윤덕현, 이상민, 이아금, 전유경, 최인학, 허주영, 홍정용, <strong>IF=5.168</strong></span></span></span></span></span></span></p>\n","pdfUrl1":"","location":null,"location1":"서울권","location2":null,"location3":null,"type":"2","applyUrl":"","fileUrl1":"","fileUrl2":"","fileUrl3":"","fileUrl4":"","fileUrl5":null,"fileUrl6":null,"fileUrl7":null,"workingHour":"7:30 ~ 17:00","contractType":"계약직","salary":"40,000,000~52,000,000","original_id":"238049968","original_domain":null,"original_url":null,"original_isPremium":null,"closeType":1,"closedAt":"2021-05-11T17:00:00.000Z","requireEducation":38,"managerTel":"02-3010-4015","managerFax":"","managerEmail":"ledmilage@gmail.com","managerName":"박효경","managerPhone":null,"managerAddress":null,"log_hit":16,"log_like":0,"publishState":1,"organizationName":null,"organizationName_en":null,"organizationName_alt":null,"del_yn":"N","createdAt":"2021-04-27T10:02:22.000Z","updatedAt":"2021-04-27T10:02:22.000Z"},"organization":{"organizationId":3353,"lv1Id":null,"lv2Id":null,"name":"서울아산병원","name_en":"Seoul Asan Hospital","name_alt":",","introduction":null,"logoImg":"","logoImgSquare":"https://s3.ap-northeast-2.amazonaws.com/jobs.ac.kr/dev/images/asan_200269152328.png","homepageUrl":"http://www.amc.seoul.kr/asan/main.do","infoUrl":null,"country":"KR","state":"서울","location":"서울권","address":"서울특별시 송파구 풍납2동 올림픽로43길 88","phoneNumber":"1688-7575","faxNumber":null,"type":14,"univType1":null,"univType2":null,"univType3":null,"univType4":null,"establishedAt":"1989-01-01T00:00:00.000Z","count_majors":null,"count_students":null,"meta_competitiveness":null,"publishState":1,"updatedAt":"2020-04-22T10:21:10.000Z","createdAt":"2020-03-04T20:13:07.000Z","default_1_bannerImage":null,"default_1_bannerImageMobile":null,"default_2_bannerImage":"https://s3.ap-northeast-2.amazonaws.com/jobs.ac.kr/dev/images/goldcopy2_1148289938592.png","default_2_bannerImageMobile":"https://s3.ap-northeast-2.amazonaws.com/jobs.ac.kr/dev/images/gold_mobilecopy2_1287992109366.png","default_3_bannerImage":null,"default_3_bannerImageMobile":null}}